Bevacizumab HS Code Trade Classification — 22 Codes, $1.6B Trade

Q: How much Bevacizumab is exported under HS code 30021500?

Under HS code 30021500, India exports $1.5B worth of Bevacizumab, representing 97.2% of total Bevacizumab trade. This involves 726 shipments from 137 Indian exporters to 194 buyers in 126 countries.

Q: Which countries import the most Bevacizumab from India?

The top importing countries for Bevacizumab from India are Russia, Netherlands, Colombia. The leading importer Russia accounts for $23.6M in trade value. In total, Bevacizumab is exported to buyers across multiple countries under 22 HS code classifications.

Q: Who are the top Bevacizumab exporters from India?

The leading Bevacizumab exporters from India include F. HOFFMANN -LA ROCHE LTD ($1.5B), F. HOFFMANN -LA ROCHE LTD., ($14.6M), DR.REDDY'S LABORATORIES LTD ($12.1M). These suppliers export across multiple HS code classifications with a combined trade value of $1.6B.

Q: Which Bevacizumab HS code has the highest unit price?

HS code 30029090 has the highest average unit price at $18555.93 per unit for Bevacizumab exports. This compares to the overall market average of $1032790.80 per transaction. The most traded code HS 30021500 averages $2019.01 per unit.

TransData Nexus

Bevacizumab

India Pharmaceutical Trade Intelligence

$46.9M196 Suppliers100 CountriesHS 30021500

ExportsIndia → RUSSIA50.3%India → NETHERLANDS14.3%

ImportsSWITZERLAND → India$1.2B GERMANY → India$344.1M

#1 Buyer: JSC R-PHARM

Bevacizumab HS Codes (2026) — 22 Classifications, $1.6B Trade | TransData Nexus | TransData Nexus

Bevacizumab HS Code Analysis (2026)

India exports Bevacizumab under 22 distinct HS code classifications, representing a total trade value of $1.6B across 1,516 shipments. The dominant classification is HS 30021500 (Immunological products, put up in measured doses or for retail sale), accounting for 97.2% of all Bevacizumab trade at $1.5B. HS 30 (Pharmaceutical product (Chapter 30)) follows at 0.8% ($13.2M). The top 5 HS codes together account for 99.9% of total Bevacizumab trade from India. The average transaction value is $1032791. Key importing markets include Russia, Netherlands, Colombia. Leading exporters include F. HOFFMANN -LA ROCHE LTD and F. HOFFMANN -LA ROCHE LTD., . Data sourced from Indian Customs (DGFT) shipping bill records.

Source:

Bevacizumab HS Code Analysis — 22 classifications, $1.6B trade value, top HS codes breakdown and distribution — Bevacizumab HS code analysis — 22 classifications · $1.6B trade value · 1,516 shipmentsTransData Nexus · Indian Customs Data

Top Bevacizumab HS Code Classifications

Ranked by trade value from Indian Customs (DGFT) data

Rank	HS Code	Trade Value	Share	Transactions	Avg Price	Suppliers	Countries
#1	30021500	$1.5B	97.2%	726	$2019.01	137	126
#2	30	$13.2M	0.8%	1

HS 30021500

Immunological products, put up in measured doses or for retail sale · 97.2% of Bevacizumab trade

$1.5B

Trade Value

97.2%

Market Share

726

Transactions

$2019.01

Avg Unit Price

Suppliers: 137Buyers: 194Countries: 126

Common Product Descriptions:

Bevacirel 400 mg, Bevacizumab 400mg

BEVACIZUMAB INJECTION 100MG (BEVACIREL 4

BEVACIZUMAB INJECTION 400MG (BEVACIREL 4

HS 30

Pharmaceutical product (Chapter 30) · 0.8% of Bevacizumab trade

$13.2M

Trade Value

0.8%

Market Share

Transactions

$5688.00

Avg Unit Price

Suppliers: 1Buyers: 1Countries: 1

Common Product Descriptions:

AVASTIN CONCENTRATE FOR SOLUTION FOR INFUSION 100M...

HS 30021300

Immunological products, unmixed, not put up in measured doses · 0.8% of Bevacizumab trade

$12.8M

Trade Value

0.8%

Market Share

Transactions

$264.05

Avg Unit Price

Suppliers: 6Buyers: 10Countries: 7

Common Product Descriptions:

BEVACIZUMAB 5 GM

BEVACIZUMAB INTERNAL REFRENCE STANDARD

BEVACIZUMAB PRS ( QTY 10 NOS) BATCH NO:P24-1-BM-C...

HS 30049049

Other gastrointestinal preparations (retail) · 0.7% of Bevacizumab trade

$11.0M

Trade Value

0.7%

Market Share

142

Transactions

$212.55

Avg Unit Price

Suppliers: 40Buyers: 50Countries: 49

Common Product Descriptions:

BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CO

BECIVRA 100 Bevacizumab 100 MG/4 ML 1's

BECIVRA 100-Bevacizumab 100 MG/4 ML (1S)

HS 30049099

Other medicaments, put up in measured doses or for retail sale · 0.4% of Bevacizumab trade

$6.0M

Trade Value

0.4%

Market Share

434

Transactions

$191.11

Avg Unit Price

Suppliers: 120Buyers: 175Countries: 110

Common Product Descriptions:

CIZUMAB 100MG INJ (Bevacizumab 100mg Inj

CIZUMAB 400MG INJ (Bevacizumab 400mg Inj

BEVACIZUMAB 400MG INJ (1 VIAL)

HS 30029090

Other blood products, toxins, cultures of micro-organisms · 0.1% of Bevacizumab trade

$908.1K

Trade Value

0.1%

Market Share

Transactions

$18555.93

Avg Unit Price

Suppliers: 16Buyers: 15Countries: 12

Common Product Descriptions:

BP01-WCB (BEVACIZUMAB WORKING CELL BANK)

BP01-MCB (BEVACIZUMAB MASTER CELL BANK)

BP01-EPCB (BEVACIZUMAB END OF PRODUCTION

HS 30021290

Other antisera and blood fractions · 0.0% of Bevacizumab trade

$134.1K

Trade Value

0.0%

Market Share

Transactions

$181.80

Avg Unit Price

Suppliers: 29Buyers: 30Countries: 31

Common Product Descriptions:

CIZUMAB 400MG (1VIAL) (BEVACIZUMAB)

BEVACIZUMAB INJECTION 400MG / 16ML

BRYXTA 100MG/4ML INJ Bevacizumab (100mg)

HS 30049042

Anti-diarrhoeal preparations, put up for retail sale · 0.0% of Bevacizumab trade

$41.3K

Trade Value

0.0%

Market Share

Transactions

$75.26

Avg Unit Price

Suppliers: 1Buyers: 2Countries: 2

Common Product Descriptions:

BEVACIZUMAB CONCENTRATE FOR SOLUTION FOR INFUSION ...

BEVACIZUMAB CONCENTRATE FOR SOLUTION FORINFUSION 4...

HS 30049036

Other medicaments of mixed or unmixed products (retail) · 0.0% of Bevacizumab trade

$25.9K

Trade Value

0.0%

Market Share

Transactions

$117.12

Avg Unit Price

Suppliers: 2Buyers: 2Countries: 2

Common Product Descriptions:

CIZUMAB 400MG/16ML VIAL BEVACIZUMAB INJ 400MG 54 V...

CIZUMAB 400MG/16ML VIAL BEVACIZUMAB INJ 400MG 48 V...

CIZUMAB 400MG/16ML VIAL BEVACIZUMAB INJ 400MG 98 V...

#10

HS 30049046

Other medicaments of mixed or unmixed products (retail) · 0.0% of Bevacizumab trade

$21.8K

Trade Value

0.0%

Market Share

Transactions

$93.42

Avg Unit Price

Suppliers: 1Buyers: 1Countries: 1

Common Product Descriptions:

REWARD ITEM HARMLESS PHARMACEUTICAL MEDICINES FOR ...

#11

HS 30042099

Medicaments containing antibiotics (retail) · 0.0% of Bevacizumab trade

$15.9K

Trade Value

0.0%

Market Share

Transactions

$307.73

Avg Unit Price

Suppliers: 3Buyers: 3Countries: 3

Common Product Descriptions:

ABEVMY 400 INJ Bevacizumab

AVASTIN 100MG BEVACIZUMAB INJECTION AVASTINBATCH N...

AVASTIN 100MG/4ML (RX BEVACIZUMAB INJECTION)LOT NO...

#12

HS 30021500

Immunological products, put up in measured doses or for retail sale · 0.0% of Bevacizumab trade

$15.0K

Trade Value

0.0%

Market Share

Transactions

$71.83

Avg Unit Price

Suppliers: 6Buyers: 7Countries: 5

Common Product Descriptions:

ABEVMY 400 MG (VIAL) (BEVACIZUMAB) (20 VIALS)

ABEVMY 400MG (VIAL) (BEVACIZUMAB) (30 VIALS)

BEVACIZUMAB 100MG INJ, BRAND NAME:BRYXTA 100, BATC...

#13

HS 30049099

Other medicaments of mixed or unmixed products (retail) · 0.0% of Bevacizumab trade

$11.1K

Trade Value

0.0%

Market Share

Transactions

$150.15

Avg Unit Price

Suppliers: 5Buyers: 5Countries: 5

Common Product Descriptions:

HARMLESS PHARMACEUTICAL MEDICINE FOR HUMAN CONSUMP...

BEVACIZUMAB 400 MG/16 ML - CIZUMAB 400 EACH ML OF ...

#14

HS 30043190

Other medicaments containing insulin (retail) · 0.0% of Bevacizumab trade

$7.8K

Trade Value

0.0%

Market Share

Transactions

$320.59

Avg Unit Price

Suppliers: 2Buyers: 3Countries: 2

Common Product Descriptions:

CIZUMAB 400 MG INJ BATCH BB2212A EXP 7 2024 BEVACI...

BEVACIZUMAB - 100MG /4ML-INJ- B7260B26

BEVACIZUMAB - 100MG /4ML-INJ

#15

HS 30041090

Other medicaments containing penicillins or streptomycins (retail) · 0.0% of Bevacizumab trade

$5.1K

Trade Value

0.0%

Market Share

Transactions

$228.62

Avg Unit Price

Suppliers: 2Buyers: 3Countries: 3

Common Product Descriptions:

PHARMACEUTICALS PRODUCTS CIZUMAB 400MG BEVACIZUMAB...

PHARMACEUTICALS PRODUCTS BEVATAS 400MG INJ BEVACIZ...

PHARMACEUTICALS PRODUCTS CIZUMAB 400MG BEVACIZUMAB...

#16

HS 30049096

Anti-obesity preparations, put up for retail sale · 0.0% of Bevacizumab trade

$3.9K

Trade Value

0.0%

Market Share

Transactions

$78.83

Avg Unit Price

Suppliers: 1Buyers: 1Countries: 1

Common Product Descriptions:

Bevatas 400Mg Bevacizumab 400mg

#17

HS 30019099

Other glands, organs and substances of human/animal origin · 0.0% of Bevacizumab trade

$2.5K

Trade Value

0.0%

Market Share

Transactions

$81.70

Avg Unit Price

Suppliers: 2Buyers: 2Countries: 2

Common Product Descriptions:

HARMLESS DRUGS AND PHARMACEUTICAL FINISHED PRODUCT...

HARMLESS PHARMACEUTICAL MEDICINE FOR HUMAN CONSUMP...

#18

HS 30019091

Human placental extract · 0.0% of Bevacizumab trade

$981

Trade Value

0.0%

Market Share

Transactions

$109.00

Avg Unit Price

Suppliers: 1Buyers: 1Countries: 1

Common Product Descriptions:

BEVATAS 400 MG BEVACIZUMAB (400MG) BATCH: 24030089...

#19

HS 30024990

Other vaccines · 0.0% of Bevacizumab trade

$569

Trade Value

0.0%

Market Share

Transactions

$284.64

Avg Unit Price

Suppliers: 1Buyers: 1Countries: 1

Common Product Descriptions:

MSQC20-0.5MG (ANTIBODY) SILU TM LITE SIGMAMAB BEVA...

#20

HS 30021400

Immunological products, mixed, not put up in measured doses · 0.0% of Bevacizumab trade

$544

Trade Value

0.0%

Market Share

Transactions

$136.04

Avg Unit Price

Suppliers: 1Buyers: 1Countries: 1

Common Product Descriptions:

ANTI-BEVACIZUMAB ANTIBODY (6C3) (BIOTIN). MAB MOUS...

ANTI-BEVACIZUMAB ANTIBODY (4H1), MAB, MOUSE (RECOM...

Where Bevacizumab is Exported — Geographic HS Code Analysis

Import destinations for Bevacizumab from India, by trade value

India exports Bevacizumab to 10+ countries under 22 HS code classifications. The largest import destination is Russia ($23.6M), followed by Netherlands ($6.7M) and Colombia ($3.7M). These markets collectively account for the majority of India's Bevacizumab pharmaceutical exports.

Rank	Country	Trade Value	Market Share
#1	Russia	$23.6M	1.5%
#2	Netherlands	$6.7M	0.4%
#3	Colombia	$3.7M	0.2%
#4	Mexico	$1.7M	0.1%
#5	Venezuela	$1.4M	0.1%
#6	Dominican Republic	$1.0M	0.1%
#7	Kenya	$930.4K	0.1%
#8	Egypt	$718.4K	0.0%
#9	Maldives	$629.7K	0.0%
#10	Brazil	$505.0K	0.0%

Pharmaceutical buyers in these markets import Bevacizumab primarily under HS code 30021500 (Immunological products, put up in measured doses or for retail sale). Import duties, regulatory requirements, and product registration vary by destination country. Contact TransData Nexus for country-specific import intelligence.

Understanding Bevacizumab HS Codes

The Harmonized System (HS) is an internationally standardized system of names and numbers to classify traded products. Developed by the World Customs Organization (WCO), it is used by over 200 countries for customs tariffs, trade statistics, and regulatory compliance. Each HS code is a 6-digit number (extended to 8 digits in India's Customs Tariff Schedule) that precisely identifies a product category.

How Bevacizumab HS Codes Work

Bevacizumab falls under Chapter 30 (Pharmaceutical Products) of the Harmonized System. The 22 codes used for Bevacizumab exports span multiple headings:

Heading 3003 — Medicaments not put up in measured doses or for retail sale (bulk APIs, intermediates)
Heading 3004 — Medicaments put up in measured doses or for retail sale (finished formulations)
Heading 3005 — Wadding, gauze, bandages for medical use
Heading 3006 — Pharmaceutical goods (sutures, reagents, dental cements)

The most significant distinction for Bevacizumab is between HS 3003 (bulk/unmeasured) and HS 3004 (retail-ready). HS 3004 codes account for the majority of Bevacizumab trade (as finished formulations ready for dispensing). The 8-digit Indian Customs Tariff code further specifies the therapeutic class — for example, HS 30021500 refers to "Immunological products, put up in measured doses or for retail sale".

Regulatory & Compliance — Bevacizumab Export Classification

Correct HS code classification is critical for Bevacizumab exports from India. Misclassification can result in customs delays, incorrect duty assessment, and regulatory penalties. Key compliance considerations for pharmaceutical stakeholders:

Import Duty Classification

Bevacizumab import duties vary significantly by HS code and destination country. HS 3004 (finished formulations) typically attracts different duty rates than HS 3003 (bulk APIs). Many developing countries offer preferential rates for essential medicines including Bevacizumab.

DGFT & Indian Customs Requirements

Indian exporters must declare the correct 8-digit ITC-HS code on shipping bills filed with the Directorate General of Foreign Trade (DGFT). Bevacizumab exports require Drug Controller General of India (DCGI) approval and must comply with Drug & Cosmetics Act regulations.

WHO Prequalification

For international procurement (UNICEF, Global Fund), Bevacizumab products must meet WHO Prequalification standards. WHO PQ status affects which HS codes are eligible for preferential procurement pricing and duty exemptions in recipient countries.

Country-Specific Registration

Each destination country requires product registration before import. Key markets like Russia and Netherlands have specific pharmaceutical regulatory bodies that must approve the product before customs clearance.

Related Advanced Oncology — Products Sharing Similar HS Codes

Other products in the Advanced Oncology therapeutic category that may share HS code classifications with Bevacizumab

actinomycin anastrozole axitinib

Tariff Schedule — Top Markets

TransData Nexus Bevacizumab HS code trade compliance intelligence

1Tariff Schedule — Top Markets

Bevacizumab is primarily classified under HS code 30021500, which pertains to immunological products, put up in measured doses or in forms or packings for retail sale. The Most-Favored-Nation (MFN) tariff rates and any preferential rates under Free Trade Agreements (FTAs) for this HS code vary across the top importing countries:

Russia: As a member of the Eurasian Economic Union (EAEU), Russia applies a common external tariff. The MFN tariff rate for HS 30021500 is typically low or zero, reflecting the essential nature of pharmaceutical products. Specific exemptions for essential medicines may apply, reducing or eliminating duties. Importers should consult the Eurasian Economic Commission for the most current rates.

Netherlands: As part of the European Union (EU), the Netherlands adheres to the EU's Common External Tariff. Pharmaceutical products under HS 30021500 generally benefit from a zero MFN tariff rate. Additionally, the EU provides exemptions for essential medicines, further facilitating the importation of such products.

Colombia: Colombia's MFN tariff rate for HS 30021500 is typically low, acknowledging the importance of pharmaceuticals. Under the India-Colombia Preferential Trade Agreement, certain pharmaceutical products may enjoy reduced tariffs. Importers should verify the specific rates and any applicable exemptions with Colombia's National Directorate of Taxes and Customs (DIAN).

Classification Disputes & Misclassification Risks

TransData Nexus Bevacizumab HS code trade compliance intelligence

1Classification Disputes & Misclassification Risks

Bevacizumab, as an immunological product, is primarily classified under HS code 30021500. However, misclassification can occur, particularly between HS codes 3003 and 3004:

HS 3003: Medicaments (excluding goods of heading 3002, 3005, or 3006) consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale.

HS 3004: Medicaments (excluding goods of heading 3002, 3005, or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale.

Common errors include misclassifying Bevacizumab under HS 30049099, which pertains to other medicaments not elsewhere specified. Our data indicates that 0.4% of shipments were classified under this code, highlighting the risk of misclassification. Such errors can lead to customs penalties, including fines and delays in clearance. Recent rulings by the World Customs Organization (WCO) and national customs authorities emphasize the importance of accurate classification to ensure compliance and facilitate trade.

TransData Nexus Research · WTO tariff schedules, WCO classification, pharmacopoeia standardsMar 2026

Pharmacopoeia & Quality Standards

TransData Nexus Bevacizumab HS code trade compliance intelligence

1Pharmacopoeia & Quality Standards

As of March 26, 2026, Bevacizumab does not have specific monographs in the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), or Indian Pharmacopoeia (IP). The absence of a monograph indicates that standardized quality specifications, including purity, assay requirements, dissolution, and stability testing, are not formally established in these compendia.

In the absence of official monographs, manufacturers and regulatory bodies rely on guidelines from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) for stability testing, particularly considering different climatic zones. Additionally, the World Health Organization (WHO) provides guidelines on the quality assurance of monoclonal antibodies, which can be applied to Bevacizumab to ensure its safety and efficacy.

It is advisable for stakeholders to stay informed about developments in pharmacopoeial standards and to consult with regulatory authorities to ensure compliance with the latest quality requirements for Bevacizumab.

TransData Nexus Research · WTO tariff schedules, WCO classification, pharmacopoeia standardsMar 2026

Frequently Asked Questions — Bevacizumab HS Codes

Common questions about Bevacizumab trade classification, answered with data from Indian Customs records.

What is the HS code for Bevacizumab exports from India?

The most commonly used HS code for Bevacizumab exports from India is 30021500 (Immunological products, put up in measured doses or for retail sale), which accounts for 97.2% of all Bevacizumab trade valued at $1.5B. In total, India exports Bevacizumab under 22 distinct HS code classifications.

How many HS codes are used for Bevacizumab trade?

Bevacizumab is exported from India under 22 different HS code classifications, covering a total trade value of $1.6B across 1,516 shipments. The top 5 HS codes account for 99.9% of total trade.

What is HS code 30021500?

HS code 30021500 refers to "Immunological products, put up in measured doses or for retail sale" under Chapter 30 (Pharmaceutical Products) of the Harmonized System. For Bevacizumab, this code covers $1.5B in trade value with 726 transactions, 137 suppliers, and 194 buyers across 126 countries. The average unit price under this code is $2019.01.

What is the difference between HS 30021500 and 30 for Bevacizumab?

HS 30021500 (Immunological products, put up in measured doses or for retail sale) accounts for 97.2% of Bevacizumab trade ($1.5B) with an average unit price of $2019.01, while HS 30 (Pharmaceutical product (Chapter 30)) covers 0.8% ($13.2M) at $5688.00 per unit. HS 30021500 involves 137 suppliers and 194 buyers, compared to 1 suppliers and 1 buyers for HS 30.

Official References & Regulatory Resources

HS code classifications follow the WCO Harmonized System. Verify tariff rates with your national customs authority.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Bevacizumab

Bevacizumab

Top Bevacizumab HS Code Classifications

All Bevacizumab HS Code Classifications

Top Suppliers

Related Analysis

Need HS Code Reports?

Where Bevacizumab is Exported — Geographic HS Code Analysis

Understanding Bevacizumab HS Codes

How Bevacizumab HS Codes Work

Regulatory & Compliance — Bevacizumab Export Classification

Import Duty Classification

DGFT & Indian Customs Requirements

WHO Prequalification

Country-Specific Registration

Related Advanced Oncology — Products Sharing Similar HS Codes

Tariff Schedule — Top Markets

1Tariff Schedule — Top Markets

Classification Disputes & Misclassification Risks

1Classification Disputes & Misclassification Risks

Pharmacopoeia & Quality Standards

1Pharmacopoeia & Quality Standards

Frequently Asked Questions — Bevacizumab HS Codes

What is the HS code for Bevacizumab exports from India?

How many HS codes are used for Bevacizumab trade?

What is HS code 30021500?

What is the difference between HS 30021500 and 30 for Bevacizumab?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

How much Bevacizumab is exported under HS code 30021500?

Which countries import the most Bevacizumab from India?

Who are the top Bevacizumab exporters from India?

Which Bevacizumab HS code has the highest unit price?

Analysis Methodology